Our research in a busy west London breast cancer service has observed developments associated with personalised medicine and healthcare – screening and diagnostic technologies, treatments, translational research, and data sharing techniques. This talk will introduce and discuss the emergence of personalised practices in this hospital service when, in 2020-21, they were affected by COVID-19.